Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation

Pioglitazone may have potential benefits as an alternative therapeutic treatment for patients with Alzheimer's disease (AD), particularly in individuals that also have comorbid diabetes; however, the mechanisms of action remain unclear. The present study aimed to explore the effects of pioglita...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sisi, Chen, Zhe, Cao, Ming, Li, Renjie, Wang, Zhigang, Zhang, Muxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428924/
https://www.ncbi.nlm.nih.gov/pubmed/28447730
http://dx.doi.org/10.3892/mmr.2017.6342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428924/
https://www.ncbi.nlm.nih.gov/pubmed/28447730
http://dx.doi.org/10.3892/mmr.2017.6342

Ejemplares similares